Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve to discuss and deliberate upon the Company''s business expansion plans in India and/or overseas, and the raising of funds/ financing thereof, in one or more tranches, through such permissible modes and means as the board of directors may deem fit, including by way of equity, debt, hybrid instruments, ....

September 29, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Prior Intimation of Board Meeting of ANLON HEALTHCARE LIMITED Respected Sir/Madam, Pursuant to Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, October 13, 2026, inter alia, to discuss and deliberate upon the Company's business expansion plans in India and/or overseas, and the raising of funds/ financing thereof, in one or more tranches, through such permissible modes and means as the board of directors may deem fit, including by way of equity, debt, hybrid instruments, borrowings, or any other mode or combination thereof, subject to applicable regulatory and other approvals. Any other matters with the permission of the Chair. You are requested to take the above information on your record Thanking You. FOR, ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in